Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

viatris limited - amoxicillin trihydrate 575mg equivalent to amoxycillin 500 mg;   - capsule - 500 mg - active: amoxicillin trihydrate 575mg equivalent to amoxycillin 500 mg   excipient: gelatin colloidal anydrous silica magnesium stearate purified talc sodium starch glycolate - amoxicillin should be used in accordance with local antibiotic-prescribing information guidelines and local susceptibility data. amoxicillin may be useful in instituting therapy prior to bacteriology; however bacteriological studies to determine the causative organisms and their sensitivity to amoxicillin should be performed. susceptibility to amoxicillin will vary with geography and time and local susceptibility data should be consulted where available and microbiological sampling and susceptibility testing performed where necessary. treatment of infection: amoxicillin is indicated in the treatment of infections due to susceptible organisms. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e. coli. respiratory (acute and chronic): h. influenzae; streptococcus; s. pneumoniae; staphylococcus, non-penicillinase-producing; e.coli. genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli, p. mirabilis and s. faecalis. gonorrhoea: n. gonorrhoeae (non-penicillinase producing). prophylaxis for endocarditis: amoxicillin may be used for the prevention of bacteraemia, associated with procedures such as dental extraction, in patients at risk of developing bacterial endocarditis, such as those with a prosthetic heart valve or those who have previously had endocarditis.

Tanzania - inglés - Tanzania Medicinces & Medical Devices Authority

salama pharmaceuticals limited, tanzania - amoxicillin - capsules - 250mg

Australia - inglés - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amoxycillin trihydrate -

Australia - inglés - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydralazine hydrochloride -

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - alpha pinene; borneol; menthol; beta pinene; menthone; camphene; cineole - oral drops, solution - percent volume/volume

Australia - inglés - APVMA (Australian Pesticides and Veterinary Medicines Authority)

alpha crop protection pty ltd - 2,4-d present as the dimethylamine and diethanolamine sa - aqueous concentrate - 2,4-d present as the dimethylamine and diethanolamine sa phenoxy acids-2,4-d active 625.0 g/l - herbicide

Australia - inglés - APVMA (Australian Pesticides and Veterinary Medicines Authority)

hemani industries limited - alpha-cypermethrin - unknown - alpha-cypermethrin pyrethroid active 0.0 - active constituent

Australia - inglés - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fatro s.p.a. - dl-alpha-tocopherol acetate 50% - unknown - dl-alpha-tocopherol acetate 50% vitamin-e active 0.0 - active constituent

Estados Unidos - inglés - NLM (National Library of Medicine)

guna spa - alpha-tocopherol (unii: h4n855pnz1) (alpha-tocopherol - unii:h4n855pnz1), laminaria digitata (unii: 15e7c67ee8) (laminaria digitata - unii:15e7c67ee8), botryoglossum platycarpum (unii: pta4328m4z) (botryoglossum platycarpum - unii:pta4328m4z), fucus serratus (unii: v8k40wnw5b) (fucus serratus - unii:v8k40wnw5b), sus scrofa capillary tissue (unii: 253a0356pn) (sus scrofa capillary tissue - unii:253a0356pn), ubidecarenone (unii: ej27x76m46) (ubidecarenone - unii:ej27x76m46), sus scrofa collagen (unii: i - alpha-tocopherol 4 [hp_c] in 4 g - alpha tocopherol        4c    antioxidant brown algae, laminaria        4c    detoxification and drainage brown algae, platycarpus    4c    detoxification and drainage brown algae, serratus        4c    detoxification and drainage capillary tissue        4c    blood flow support coenzyme q-10            4c    antioxidant collagen            4c    eutrophic action fucus vesiculosus        4c    detoxification isoleucine            4c    dermis protein metabolic support knotted wrack            4c    skin tone support leucine                4c    dermis protein metabolic support placenta totalis        4c    vascular stimulation retinol                4c    antioxidant sea lettuce            4c    skin tone selenium metallicum        4c    cell metabolic support skin tissue            4c    eutrophic supp

Australia - inglés - Department of Health (Therapeutic Goods Administration)

grifols australia pty ltd - alpha-1-proteinase inhibitor, quantity: 1000 mg - solution - excipient ingredients: monobasic sodium phosphate; alanine; water for injections - prolastin? c liquid is an alpha-1-proteinase inhibitor indicated to increase serum alpha-1-proteinase inhibitor levels in adults with congenital deficiency of alpha-1-antitrypsin and with clinically significant emphysema (fev1 <80%).,the data for clinical efficacy of prolastin? c liquid is derived from changes in the biomarkers alpha-1 anti-protease level and ct lung density. efficacy on fev1 or patient relevant endpoints such as quality of life or pulmonary exacerbations has not been established in randomised clinical trials.,clinical trials have only included patients who were not smoking.